During the past decade, Oregon Retina, LLP conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 9 clinical trials were completed. i.e. 450% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oregon Retina, LLP" #1 sponsor was "Jaeb Center for Health Research" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Aldeyra Therapeutics, Inc." with 1 trials sponsored and "Allergan" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oregon Retina, LLP" #1 collaborator was "National Eye Institute (NEI)" with 5 trials as a collaborator, "National Institutes of Health (NIH)" with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator and "MEDARVA Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Oregon Retina, LLP" are "Diabetic Macular Edema" (3 trials), "Geographic Atrophy" (3 trials), "Choroidal Neovascularization" (1 trials), "Diabetic Retinopathy" (1 trials) and "Dry Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Oregon Retina, LLP" in a lesser frequency.

Most popular intervention types in "Oregon Retina, LLP" are "Drug" (12 trials), "Other" (3 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (3 trials), "Ranibizumab" (3 trials), "Sham Procedure" (3 trials), "Deferred aflibercept" (2 trials) and "Deferred laser" (2 trials). Other intervention names were less common.

The vast majority of trials in "Oregon Retina, LLP" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Oregon Retina, LLP". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Oregon Retina, LLP, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oregon Retina, LLP, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".